{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:22:30Z","timestamp":1759530150622,"version":"3.41.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T00:00:00Z","timestamp":1492732800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T00:00:00Z","timestamp":1492732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH020065"],"award-info":[{"award-number":["MH020065"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA02812"],"award-info":[{"award-number":["DA02812"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM007281"],"award-info":[{"award-number":["GM007281"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s00213-017-4621-x","type":"journal-article","created":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T12:00:03Z","timestamp":1492776003000},"page":"2159-2166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["MDMA does not alter responses to the Trier Social Stress Test in humans"],"prefix":"10.1007","volume":"234","author":[{"given":"Anya K.","family":"Bershad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harriet","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,21]]},"reference":[{"key":"4621_CR1","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.psyneuen.2009.06.011","volume":"34","author":"EK Adam","year":"2009","unstructured":"Adam EK, Kumari M (2009) Assessing salivary cortisol in large-scale, epidemiological research. Psychoneuroendocrinology 34:1423\u20131436","journal-title":"Psychoneuroendocrinology"},{"key":"4621_CR2","doi-asserted-by":"publisher","unstructured":"Baggott MJ, Coyle JR, Siegrist JD, Garrison KJ, Galloway GP, Mendelson JE (2015) Effects of MDMA on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled setting. doi: 10.1101\/021329","DOI":"10.1101\/021329"},{"key":"4621_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00213-009-1635-z","volume":"207","author":"G Bedi","year":"2009","unstructured":"Bedi G, Phan KL, Angstadt M, de Wit H (2009) Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology 207:73\u201383","journal-title":"Psychopharmacology"},{"key":"4621_CR4","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.biopsych.2010.08.003","volume":"68","author":"G Bedi","year":"2010","unstructured":"Bedi G, Hyman D, de Wit H (2010) Is ecstasy an \"empathogen\": effects of \u00b13, 4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others. Biol Psychiatry 68:1134\u20131140","journal-title":"Biol Psychiatry"},{"key":"4621_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116663120","author":"AK Bershad","year":"2016","unstructured":"Bershad AK, Miller MA, Baggott MJ, de Wit H (2016) The effects of MDMA on socio-emotional processing: does MDMA differ from other stimulants? J Psychopharmacol. doi: 10.1177\/0269881116663120","journal-title":"J Psychopharmacol"},{"key":"4621_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/02791072.2008.10400637","volume":"40","author":"JC Bouso","year":"2008","unstructured":"Bouso JC, Doblin R, Farre M, Alcazar MA, Gomez-Jarabo G (2008) MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder. J Psychoactive Drugs 40:225\u2013236","journal-title":"J Psychoactive Drugs"},{"key":"4621_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000026668","volume":"42","author":"HV Curran","year":"2000","unstructured":"Curran HV (2000) Is MDMA (\u2018ecstasy\u2019) neurotoxic in humans? An overview of evidence and of methodological problems in research. Neuropsychobiology 42:34\u201341","journal-title":"Neuropsychobiology"},{"key":"4621_CR8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/17470910802649470","volume":"4","author":"G Dumont","year":"2009","unstructured":"Dumont G, Sweep F, Van der Steen R, Hermsen R, Donders A, Touw D, van Gerven J, Buitelaar J, Verkes R (2009) Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3, 4-methylenedioxymethamphetamine) administration. Soc Neurosci 4:359\u2013366","journal-title":"Soc Neurosci"},{"key":"4621_CR9","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1111\/j.1360-0443.1991.tb01749.x","volume":"86","author":"MW Fischman","year":"1991","unstructured":"Fischman MW, Foltin RW (1991) Utility of subjective effects measurements in assessing abuse liability of drugs in humans. Br J Addict 86:1563\u20131570","journal-title":"Br J Addict"},{"key":"4621_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pbb.2013.11.030","volume":"117","author":"CG Frye","year":"2014","unstructured":"Frye CG, Wardle MC, Norman GJ, de Wit H (2014) MDMA decreases the effects of simulated social rejection. Pharmacol Biochem Behav 117:1\u20136","journal-title":"Pharmacol Biochem Behav"},{"key":"4621_CR11","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.psyneuen.2005.02.001","volume":"30","author":"J Gaab","year":"2005","unstructured":"Gaab J, Rohleder N, Nater U, Ehlert U (2005) Psychological determinants of the cortisol stress response: the role of anticipatory cognitive appraisal. Psychoneuroendocrinology 30:599\u2013610","journal-title":"Psychoneuroendocrinology"},{"key":"4621_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0165-1781(03)00175-6","volume":"120","author":"G Gerra","year":"2003","unstructured":"Gerra G, Bassignana S, Zaimovic A, Moi G, Bussandri M, Caccavari R, Brambilla F, Molina E (2003) Hypothalamic\u2013pituitary\u2013adrenal axis responses to stress in subjects with 3, 4-methylenedioxy-methamphetamine (\u2018ecstasy\u2019) use history: correlation with dopamine receptor sensitivity. Psychiatry Res 120:115\u2013124","journal-title":"Psychiatry Res"},{"key":"4621_CR13","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s00213-002-1131-1","volume":"162","author":"DS Harris","year":"2002","unstructured":"Harris DS, Baggott M, Mendelson JH, Mendelson JE, Jones RT (2002) Subjective and hormonal effects of 3, 4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology 162:396","journal-title":"Psychopharmacology"},{"key":"4621_CR14","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0006-3223(03)00465-7","volume":"54","author":"M Heinrichs","year":"2003","unstructured":"Heinrichs M, Baumgartner T, Kirschbaum C, Ehlert U (2003) Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol Psychiatry 54:1389\u20131398","journal-title":"Biol Psychiatry"},{"key":"4621_CR15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/clpt.2011.78","volume":"90","author":"C Hysek","year":"2011","unstructured":"Hysek C, Simmler L, Ineichen M, Grouzmann E, Hoener M, Brenneisen R, Huwyler J, Liechti M (2011) The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA (\u201cecstasy\u201d) in humans. Clinical pharmacology & therapeutics 90:246\u2013255","journal-title":"Clinical pharmacology & therapeutics"},{"key":"4621_CR16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00213-012-2645-9","volume":"222","author":"CM Hysek","year":"2012","unstructured":"Hysek CM, Domes G, Liechti ME (2012) MDMA enhances \u201cmind reading\u201d of positive emotions and impairs \u201cmind reading\u201d of negative emotions. Psychopharmacology 222:293\u2013302","journal-title":"Psychopharmacology"},{"key":"4621_CR17","doi-asserted-by":"crossref","unstructured":"Hysek CM, Schmid Y, Simmler LD, Domes G, Heinrichs M, Eisenegger C, Preller KH, Quednow BB, Liechti ME (2013) MDMA enhances emotional empathy and prosocial behavior. Soc Cogn Affect Neurosci 9:1645","DOI":"10.1093\/scan\/nst161"},{"key":"4621_CR18","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.neubiorev.2015.08.016","volume":"57","author":"P Kamilar-Britt","year":"2015","unstructured":"Kamilar-Britt P, Bedi G (2015) The prosocial effects of 3, 4-methylenedioxymethamphetamine (MDMA): controlled studies in humans and laboratory animals. Neurosci Biobehav Rev 57:433\u2013446","journal-title":"Neurosci Biobehav Rev"},{"key":"4621_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00213-011-2383-4","volume":"219","author":"MG Kirkpatrick","year":"2012","unstructured":"Kirkpatrick MG, Gunderson EW, Perez AY, Haney M, Foltin RW, Hart CL (2012) A direct comparison of the behavioral and physiological effects of methamphetamine and 3, 4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology 219:109\u2013122","journal-title":"Psychopharmacology"},{"key":"4621_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.psyneuen.2014.04.006","volume":"46","author":"MG Kirkpatrick","year":"2014","unstructured":"Kirkpatrick MG, Francis SM, Lee R, de Wit H, Jacob S (2014a) Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humans. Psychoneuroendocrinology 46:23\u201331","journal-title":"Psychoneuroendocrinology"},{"key":"4621_CR21","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1038\/npp.2014.12","volume":"39","author":"MG Kirkpatrick","year":"2014","unstructured":"Kirkpatrick MG, Lee R, Wardle MC, Jacob S, de Wit H (2014b) Effects of MDMA and intranasal oxytocin on social and emotional processing. Neuropsychopharmacology 39:1654\u20131663","journal-title":"Neuropsychopharmacology"},{"key":"4621_CR22","doi-asserted-by":"publisher","DOI":"10.1177\/0269881115573806","author":"M Kirkpatrick","year":"2015","unstructured":"Kirkpatrick M, Delton AW, de Wit H, Robertson TE (2015) Prosocial effects of MDMA: a measure of generosity. J Psychopharmacol. doi: 10.1177\/0269881115573806","journal-title":"J Psychopharmacol"},{"key":"4621_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000119004","volume":"28","author":"C Kirschbaum","year":"1993","unstructured":"Kirschbaum C, Pirke K-M, Hellhammer DH (1993) The \u2018Trier social stress test\u2019\u2014a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 28:76\u201381","journal-title":"Neuropsychobiology"},{"key":"4621_CR24","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/00006842-199903000-00006","volume":"61","author":"C Kirschbaum","year":"1999","unstructured":"Kirschbaum C, Kudielka BM, Gaab J, Schommer NC, Hellhammer DH (1999) Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Psychosom Med 61:154\u2013162","journal-title":"Psychosom Med"},{"key":"4621_CR25","unstructured":"Kudielka BM, Hellhammer DH, Kirschbaum C, Harmon-Jones E, Winkielman P (2007) Ten years of research with the Trier social stress test\u2014revisited. Social neuroscience: Integrating biological and psychological explanations of social behavior:56\u201383"},{"key":"4621_CR26","doi-asserted-by":"publisher","first-page":"e100719","DOI":"10.1371\/journal.pone.0100719","volume":"9","author":"KP Kuypers","year":"2014","unstructured":"Kuypers KP, de la Torre R, Farre M, Yubero-Lahoz S, Dziobek I, Van den Bos W, Ramaekers JG (2014) No evidence that MDMA-induced enhancement of emotional empathy is related to peripheral oxytocin levels or 5-HT 1a receptor activation. PLoS One 9:e100719","journal-title":"PLoS One"},{"key":"4621_CR27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-3565(24)34877-3","volume":"290","author":"M Mas","year":"1999","unstructured":"Mas M, Farr\u00e9 M, de la Torre R, Roset PN, Ortu\u00f1o J, Segura J, Cam\u00ed J (1999) Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans. J Pharmacol Exp Ther 290:136\u2013145","journal-title":"J Pharmacol Exp Ther"},{"key":"4621_CR28","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1177\/0269881110378371","volume":"25","author":"MC Mithoefer","year":"2011","unstructured":"Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Doblin R (2011) The safety and efficacy of\u00b13, 4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. J Psychopharmacol 25:439\u2013452","journal-title":"J Psychopharmacol"},{"key":"4621_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/0269881112456611","volume":"27","author":"M Mithoefer","year":"2013","unstructured":"Mithoefer M, Wagner M, Mithoefer A, Jerome L, Martin S, Yazar-Klosinski B (2013) Durability of improvement in PTSD symptoms and absence of harmful effects or drug dependency after MDMA-assisted psychotherapy: a prospective long-term follow-up study. J Psychopharmacol 27:28\u201339","journal-title":"J Psychopharmacol"},{"key":"4621_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00213-012-2954-z","volume":"227","author":"ME Morean","year":"2013","unstructured":"Morean ME, de Wit H, King AC, Sofuoglu M, Rueger SY, O\u2019Malley SS (2013) The drug effects questionnaire: psychometric support across three drug types. Psychopharmacology 227:177\u2013192","journal-title":"Psychopharmacology"},{"key":"4621_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1177\/0269881112464827","volume":"27","author":"P Oehen","year":"2013","unstructured":"Oehen P, Traber R, Widmer V, Schnyder U (2013) A randomized, controlled pilot study of MDMA (\u00b13, 4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD). J Psychopharmacol 27:40\u201352","journal-title":"J Psychopharmacol"},{"key":"4621_CR32","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/hup.351","volume":"16","author":"AC Parrott","year":"2001","unstructured":"Parrott AC (2001) Human psychopharmacology of ecstasy (MDMA): a review of 15 years of empirical research. Hum Psychopharmacol Clin Exp 16:557\u2013577","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"4621_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1159\/000080961","volume":"50","author":"AC Parrott","year":"2004","unstructured":"Parrott AC (2004) MDMA (3, 4-Methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and raves. Neuropsychobiology 50:329\u2013335","journal-title":"Neuropsychobiology"},{"key":"4621_CR34","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000253551","volume":"60","author":"AC Parrott","year":"2009","unstructured":"Parrott AC (2009) Cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of bioenergetic stress in ecstasy users. Neuropsychobiology 60:148\u2013158","journal-title":"Neuropsychobiology"},{"key":"4621_CR35","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1177\/0269881112454231","volume":"27","author":"AC Parrott","year":"2013","unstructured":"Parrott AC, Lock J, Adnum L, Thome J (2013) MDMA can increase cortisol levels by 800% in dance clubbers. J Psychopharmacol 27:113\u2013114","journal-title":"J Psychopharmacol"},{"key":"4621_CR36","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/FBP.0000000000000060","volume":"25","author":"AC Parrott","year":"2014","unstructured":"Parrott AC, Montgomery C, Wetherell MA, Downey LA, Stough C, Scholey AB (2014) MDMA, cortisol, and heightened stress in recreational ecstasy users. Behav Pharmacol 25:458\u2013472","journal-title":"Behav Pharmacol"},{"key":"4621_CR37","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1177\/0269881105058777","volume":"20","author":"J Rodgers","year":"2006","unstructured":"Rodgers J, Buchanan T, Pearson C, Parrott AC, Ling J, Heffernan T, Scholey AB (2006) Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study. J Psychopharmacol 20:437\u2013446","journal-title":"J Psychopharmacol"},{"key":"4621_CR38","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1177\/0269881114542454","volume":"28","author":"Y Schmid","year":"2014","unstructured":"Schmid Y, Hysek CM, Simmler LD, Crockett MJ, Quednow BB, Liechti ME (2014) Differential effects of MDMA and methylphenidate on social cognition. J Psychopharmacol 28:847\u2013856","journal-title":"J Psychopharmacol"},{"key":"4621_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000364879","volume":"100","author":"J Seibert","year":"2014","unstructured":"Seibert J, Hysek CM, Penno CA, Schmid Y, Kratschmar DV, Liechti ME, Odermatt A (2014) Acute effects of 3, 4-methylenedioxymethamphetamine and methylphenidate on circulating steroid levels in healthy subjects. Neuroendocrinology 100:17\u201325","journal-title":"Neuroendocrinology"},{"key":"4621_CR40","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.neuroscience.2007.02.032","volume":"146","author":"M Thompson","year":"2007","unstructured":"Thompson M, Callaghan P, Hunt G, Cornish J, McGregor I (2007) A role for oxytocin and 5-HT1A receptors in the prosocial effects of 3, 4 methylenedioxymethamphetamine (\u201cecstasy\u201d). Neuroscience 146:509\u2013514","journal-title":"Neuroscience"},{"key":"4621_CR41","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1749-6632.2000.tb05199.x","volume":"914","author":"R Torre","year":"2000","unstructured":"Torre R, Farre M, Roset P, L\u00f3pez CH, Mas M, Ortuno J, Menoyo E, Pizarro N, Segura J, Cami J (2000) Pharmacology of MDMA in humans. Ann N Y Acad Sci 914:225\u2013237","journal-title":"Ann N Y Acad Sci"},{"key":"4621_CR42","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/sj.npp.1395197","volume":"19","author":"FX Vollenweider","year":"1998","unstructured":"Vollenweider FX, Gamma A, Liechti M, Huber T (1998) Psychological and cardiovascular effects and short-term sequelae of MDMA (\u201cecstasy\u201d) in MDMA-naive healthy volunteers. Neuropsychopharmacology 19:241\u2013251","journal-title":"Neuropsychopharmacology"},{"key":"4621_CR43","doi-asserted-by":"crossref","unstructured":"Wardle MC, de Wit H (2014) MDMA alters emotional processing and facilitates positive social interaction. Psychopharmacology 231:4219\u20134229","DOI":"10.1007\/s00213-014-3570-x"},{"key":"4621_CR44","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1093\/scan\/nsu035","volume":"9","author":"MC Wardle","year":"2014","unstructured":"Wardle MC, Kirkpatrick MG, de Wit H (2014) \u2018Ecstasy\u2019as a social drug: MDMA preferentially affects responses to emotional stimuli with social content. Soc Cogn Affect Neurosci 9:1076\u20131081","journal-title":"Soc Cogn Affect Neurosci"},{"key":"4621_CR45","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0091-3057(02)00818-3","volume":"73","author":"TL White","year":"2002","unstructured":"White TL, Justice AJ, de Wit H (2002) Differential subjective effects of D-amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacol Biochem Behav 73:729\u2013741","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-017-4621-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-017-4621-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-017-4621-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T23:36:08Z","timestamp":1750203368000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-017-4621-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,21]]},"references-count":45,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["4621"],"URL":"https:\/\/doi.org\/10.1007\/s00213-017-4621-x","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"type":"print","value":"0033-3158"},{"type":"electronic","value":"1432-2072"}],"subject":[],"published":{"date-parts":[[2017,4,21]]},"assertion":[{"value":"13 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This research was supported by DA02812. M.A.M was supported by a National Institute of Mental Health training grant (T32 MH020065) and A.K.B. was supported by a training grant from the National Institute of General Medical Sciences (T32 GM007281).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}